Hospice News June 29, 2022
Jim Parker

Congressional legislators are casting doubts on regulatory oversight of Medicare Advantage plans over concerns about spending, claims denials, and end-of-life care.

Several lawmakers expressed these reservations during a House Energy and Commerce Committee’s Oversight and Investigation subcommittee hearing that focused on the Medicare Advantage program.

“Improper claim denials and increased use of prior authorizations are preventing beneficiaries from receiving the care they need,” Energy and Commerce Chairman Frank Pallone, Jr. (D-N.J.) said during the hearing. “While there are many plans that appear to be acting responsibly, some are not, and these bad actors are costing taxpayers money and, more importantly, jeopardizing the health of seniors.”

Officials from several federal agencies testified, including the U.S. Department of Health & Human Services...

Today's Sponsors

Oliver Wyman
Patient Bond
pCare

Today's Sponsors

Amwell
Oliver Wyman

Today's Sponsor

Patient Bond

 
Topics: CMS, Congress / White House, Govt Agencies, Insurance, Medicare Advantage, OIG, Survey / Study, Trends
Webinar Recap: In-Home Care is Here to Stay: How Medicare Advantage is Innovating to Meet Beneficiaries Where They Are
Largest Medicare Advantage Plans Pay Large Markups for Dialysis, Could Increase Out-of-Pocket Spending
HCSC expanding Medicare Advantage footprint to 150 new counties
Filling The Gaps: The Role And Value Of Supplemental Benefits In Medicare Advantage
SCAN plans to expand Medicare Advantage offerings into Texas